Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan
Mingming Yang, Jawad H. Butt, Toru Kondo, Karola S. Jering, Kieran F. Docherty, Pardeep S. Jhund, Rudolf A. de Boer, Brian L. Claggett, Akshay S. Desai, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S.P. Lam, Anna Maria Langkilde, Felipe A. Martinez, Magnus Petersson, Sanjiv J. Shah, Muthiah Vaduganathan, Ulrica Wilderäng, Scott D. SolomonJohn J.V. McMurray*
Research output: Contribution to journal › Article › Academic › peer-review
2Citations
(Scopus)
25Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan'. Together they form a unique fingerprint.